LABU Direxion Daily S&P Biotech Bull 3X Shares
Issuer
Direxion
Inception
May 28, 2015
AUM
$597.7M
Expense ratio
0.96%
Yield
0.44%
Asset class
Leveraged/Inverse
Holdings
156
Last price
$207.00
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.
+62.3%
2025-11-13low 126.79 · high 341.552026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| LABU | -1.5% | -25.2% | +29.8% | +64.0% | +48.2% | -28.1% |
| Leveraged/Inverse average (155 funds) | -12.5% | -14.1% | -22.1% | -24.5% | -23.4% | -19.0% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$564K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| KOD KODIAK SCIENCES INC | 0.27% | $181.3M | $2.7M |
| MDGL MADRIGAL PHARMACEUTICALS INC | 0.22% | $35.0M | $7.0M |
| SRRK SCHOLAR ROCK HOLDING CORP | 0.16% | $12.0M | $0 |
| PRTA PROTHENA CORP PLC | 0.02% | $9.8M | $0 |
| INBX INHIBRX BIOSCIENCES INC | 0.06% | $6.3M | $279K |
| KURA KURA ONCOLOGY INC | 0.04% | $2.4M | $1.7M |
| RGNX REGENXBIO INC | 0.03% | $949K | $0 |
| ALNY ALNYLAM PHARMACEUTICALS INC | 0.17% | $543K | $399K |
| DMRA DAMORA THERAPEUTICS INC | 0.03% | $253K | $0 |
| ANNX ANNEXON INC | 0.05% | $100K | $0 |
| DYN DYNE THERAPEUTICS INC | 0.15% | $40K | $248K |
| VNDA VANDA PHARMACEUTICALS INC | 0.01% | $38K | $0 |
| PGEN PRECIGEN INC | 0.05% | $25K | $2.3M |
| CMPX COMPASS THERAPEUTICS INC | 0.01% | $21K | $0 |
| TYRA TYRA BIOSCIENCES INC | 0.05% | $20K | $0 |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LABU SPSIBI SWAP ASSET LEG (SPSIBICTL) | 18.98% |
| 2 | MRNA MODERNA INC | 0.52% |
| 3 | SYRE SPYRE THERAPEUTICS INC | 0.35% |
| 4 | EXEL EXELIXIS INC | 0.34% |
| 5 | TGTX TG THERAPEUTICS INC | 0.34% |
| 6 | BIIB BIOGEN INC | 0.34% |
| 7 | AMGN AMGEN INC | 0.34% |
| 8 | REGN REGENERON PHARMACEUTICALS | 0.33% |
| 9 | ABBV ABBVIE INC | 0.33% |
| 10 | UTHR UNITED THERAPEUTICS CORP | 0.33% |
| 11 | ORKA ORUKA THERAPEUTICS INC | 0.33% |
| 12 | GILD GILEAD SCIENCES INC | 0.33% |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | 0.32% |
| 14 | ALKS ALKERMES PLC | 0.30% |
| 15 | VRTX VERTEX PHARMACEUTICALS INC | 0.30% |
| 16 | BBIO BRIDGEBIO PHARMA INC | 0.29% |
| 17 | PRAX PRAXIS PRECISION MEDICINES I | 0.28% |
| 18 | ROIV ROIVANT SCIENCES LTD | 0.28% |
| 19 | TWST TWIST BIOSCIENCE CORP | 0.27% |
| 20 | KYMR KYMERA THERAPEUTICS INC | 0.27% |
| 21 | INCY INCYTE CORP | 0.27% |
| 22 | NTRA NATERA INC | 0.27% |
| 23 | PTCT PTC THERAPEUTICS INC | 0.27% |
| 24 | ERAS ERASCA INC | 0.27% |
| 25 | KOD KODIAK SCIENCES INC | 0.27% |
| 26 | HALO HALOZYME THERAPEUTICS INC | 0.27% |
| 27 | INSM INSMED INC | 0.26% |
| 28 | PTGX PROTAGONIST THERAPEUTICS INC | 0.26% |
| 29 | PCVX VAXCYTE INC | 0.26% |
| 30 | BMRN BIOMARIN PHARMACEUTICAL INC | 0.25% |
| 31 | RYTM RHYTHM PHARMACEUTICALS INC | 0.25% |
| 32 | KRYS KRYSTAL BIOTECH INC | 0.25% |
| 33 | RVMD REVOLUTION MEDICINES INC | 0.24% |
| 34 | CRSP CRISPR THERAPEUTICS AG | 0.24% |
| 35 | GRAL GRAIL INC | 0.24% |
| 36 | DNTH DIANTHUS THERAPEUTICS INC | 0.23% |
| 37 | MDGL MADRIGAL PHARMACEUTICALS INC | 0.22% |
| 38 | CYTK CYTOKINETICS INC | 0.22% |
| 39 | MIRM MIRUM PHARMACEUTICALS INC | 0.22% |
| 40 | TVTX TRAVERE THERAPEUTICS INC | 0.22% |
| 41 | COGT COGENT BIOSCIENCES INC | 0.22% |
| 42 | CGON CG ONCOLOGY INC | 0.21% |
| 43 | CDNA CAREDX INC | 0.20% |
| 44 | TNGX TANGO THERAPEUTICS INC | 0.20% |
| 45 | VKTX VIKING THERAPEUTICS INC | 0.19% |
| 46 | RLAY RELAY THERAPEUTICS INC | 0.18% |
| 47 | ALNY ALNYLAM PHARMACEUTICALS INC | 0.17% |
| 48 | IOVA IOVANCE BIOTHERAPEUTICS INC | 0.17% |
| 49 | BEAM BEAM THERAPEUTICS INC | 0.17% |
| 50 | ARWR ARROWHEAD PHARMACEUTICALS IN | 0.17% |
| 51 | ARQT ARCUTIS BIOTHERAPEUTICS INC | 0.16% |
| 52 | RARE ULTRAGENYX PHARMACEUTICAL IN | 0.16% |
| 53 | SRRK SCHOLAR ROCK HOLDING CORP | 0.16% |
| 54 | DYN DYNE THERAPEUTICS INC | 0.15% |
| 55 | IMVT IMMUNOVANT INC | 0.15% |
| 56 | VRDN VIRIDIAN THERAPEUTICS INC | 0.15% |
| 57 | IBRX IMMUNITYBIO INC | 0.15% |
| 58 | CELC CELCUITY INC | 0.15% |
| 59 | IONS IONIS PHARMACEUTICALS INC | 0.14% |
| 60 | VCEL VERICEL CORP | 0.13% |
| 61 | IRON DISC MEDICINE INC | 0.12% |
| 62 | SMMT SUMMIT THERAPEUTICS INC | 0.12% |
| 63 | DNLI DENALI THERAPEUTICS INC | 0.12% |
| 64 | ADMA ADMA BIOLOGICS INC | 0.11% |
| 65 | RXRX RECURSION PHARMACEUTICALS-A | 0.11% |
| 66 | PVLA PALVELLA THERAPEUTICS INC | 0.11% |
| 67 | VCYT VERACYTE INC | 0.11% |
| 68 | BHVN BIOHAVEN LTD | 0.11% |
| 69 | VERA VERA THERAPEUTICS INC | 0.11% |
| 70 | AGIO AGIOS PHARMACEUTICALS INC | 0.11% |
| 71 | PURR HYPERLIQUID STRATEGIES | 0.10% |
| 72 | REPL REPLIMUNE GROUP INC | 0.10% |
| 73 | BCRX BIOCRYST PHARMACEUTICALS INC | 0.10% |
| 74 | XNCR XENCOR INC | 0.10% |
| 75 | IDYA IDEAYA BIOSCIENCES INC | 0.10% |
| 76 | ABSI ABSCI CORP | 0.10% |
| 77 | QURE UNIQURE NV | 0.10% |
| 78 | SRPT SAREPTA THERAPEUTICS INC | 0.09% |
| 79 | NTLA INTELLIA THERAPEUTICS INC | 0.09% |
| 80 | CLDX CELLDEX THERAPEUTICS INC | 0.09% |
| 81 | SLS SELLAS LIFE SCIENCES GROUP I | 0.09% |
| 82 | NVAX NOVAVAX INC | 0.09% |
| 83 | ACAD ACADIA PHARMACEUTICALS INC | 0.09% |
| 84 | TRAX FIRST TRACKS BIOTHERAPEUTICS | 0.08% |
| 85 | RCUS ARCUS BIOSCIENCES INC | 0.07% |
| 86 | NKTR NEKTAR THERAPEUTICS | 0.07% |
| 87 | IMNM IMMUNOME INC | 0.07% |
| 88 | STOK STOKE THERAPEUTICS INC | 0.07% |
| 89 | NRIX NURIX THERAPEUTICS INC | 0.07% |
| 90 | VIR VIR BIOTECHNOLOGY INC | 0.06% |
| 91 | ANAB ANAPTYSBIO INC | 0.06% |
| 92 | MNKD MANNKIND CORP | 0.06% |
| 93 | ZBIO ZENAS BIOPHARMA INC | 0.06% |
| 94 | INBX INHIBRX BIOSCIENCES INC | 0.06% |
| 95 | JBIO JADE BIOSCIENCES INC | 0.05% |
| 96 | PGEN PRECIGEN INC | 0.05% |
| 97 | ANNX ANNEXON INC | 0.05% |
| 98 | SNDX SYNDAX PHARMACEUTICALS INC | 0.05% |
| 99 | TYRA TYRA BIOSCIENCES INC | 0.05% |
| 100 | MLYS MINERALYS THERAPEUTICS INC | 0.05% |
| 101 | ARDX ARDELYX INC | 0.04% |
| 102 | TSHA TAYSHA GENE THERAPIES INC | 0.04% |
| 103 | VOR VOR BIOPHARMA INC | 0.04% |
| 104 | ORIC ORIC PHARMACEUTICALS INC | 0.04% |
| 105 | GLUE MONTE ROSA THERAPEUTICS INC | 0.04% |
| 106 | RIGL RIGEL PHARMACEUTICALS INC | 0.04% |
| 107 | CRVS CORVUS PHARMACEUTICALS INC | 0.04% |
| 108 | VSTM VERASTEM INC | 0.04% |
| 109 | COAG HEMAB THERAPEUTICS HOLDINGS | 0.04% |
| 110 | CADL CANDEL THERAPEUTICS INC | 0.04% |
| 111 | CAPR CAPRICOR THERAPEUTICS INC | 0.04% |
| 112 | KURA KURA ONCOLOGY INC | 0.04% |
| 113 | GERN GERON CORP | 0.04% |
| 114 | IMMX IMMIX BIOPHARMA INC | 0.03% |
| 115 | KLRA KAILERA THERAPEUTICS INC | 0.03% |
| 116 | OLMA OLEMA PHARMACEUTICALS INC | 0.03% |
| 117 | DMRA DAMORA THERAPEUTICS INC | 0.03% |
| 118 | RGNX REGENXBIO INC | 0.03% |
| 119 | MYGN MYRIAD GENETICS INC | 0.03% |
| 120 | IRWD IRONWOOD PHARMACEUTICALS INC | 0.03% |
| 121 | SVRA SAVARA INC | 0.03% |
| 122 | PRME PRIME MEDICINE INC | 0.03% |
| 123 | FDMT 4D MOLECULAR THERAPEUTICS IN | 0.03% |
| 124 | SGMT SAGIMET BIOSCIENCES INC-A | 0.03% |
| 125 | JANX JANUX THERAPEUTICS INC | 0.03% |
| 126 | CGEM CULLINAN THERAPEUTICS INC | 0.03% |
| 127 | ACHV ACHIEVE LIFE SCIENCES INC | 0.03% |
| 128 | SLDB SOLID BIOSCIENCES INC | 0.03% |
| 129 | CLYM CLIMB BIO INC | 0.03% |
| 130 | AVTX AVALO THERAPEUTICS INC | 0.02% |
| 131 | SANA SANA BIOTECHNOLOGY INC | 0.02% |
| 132 | AVBP ARRIVENT BIOPHARMA INC | 0.02% |
| 133 | BCAX BICARA THERAPEUTICS INC | 0.02% |
| 134 | ABUS ARBUTUS BIOPHARMA CORP | 0.02% |
| 135 | CTMX CYTOMX THERAPEUTICS INC | 0.02% |
| 136 | OCGN OCUGEN INC | 0.02% |
| 137 | EDIT EDITAS MEDICINE INC | 0.02% |
| 138 | DSGN DESIGN THERAPEUTICS INC | 0.02% |
| 139 | MNPR MONOPAR THERAPEUTICS INC | 0.02% |
| 140 | EBS EMERGENT BIOSOLUTIONS INC | 0.02% |
| 141 | STTK SHATTUCK LABS INC | 0.02% |
| 142 | AKTS AKTIS ONCOLOGY INC | 0.02% |
| 143 | SPRY ARS PHARMACEUTICALS INC | 0.02% |
| 144 | ALT ALTIMMUNE INC | 0.02% |
| 145 | ALLO ALLOGENE THERAPEUTICS INC | 0.02% |
| 146 | PRTA PROTHENA CORP PLC | 0.02% |
| 147 | OVID OVID THERAPEUTICS INC | 0.01% |
| 148 | VNDA VANDA PHARMACEUTICALS INC | 0.01% |
| 149 | CABA CABALETTA BIO INC | 0.01% |
| 150 | AURA AURA BIOSCIENCES INC | 0.01% |
| 151 | ASMB ASSEMBLY BIOSCIENCES INC | 0.01% |
| 152 | NGNE NEUROGENE INC | 0.01% |
| 153 | MDXG MIMEDX GROUP INC | 0.01% |
| 154 | CBIO CRESCENT BIOPHARMA INC | 0.01% |
| 155 | LXEO LEXEO THERAPEUTICS INC | 0.01% |
| 156 | CMPX COMPASS THERAPEUTICS INC | 0.01% |
| 157 | FTH FAETH THERAPEUTICS INC | 0.01% |
| 158 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 0.00% |
| 159 | 2200963 OMNIAB INC - 12.5 EARNOUT | 0.00% |
| 160 | 2200964 OMNIAB INC - 15.00 EARNOUT | 0.00% |
Sector breakdown
Healthcare99.3%
Financial Services0.7%
Country breakdown
United States86.5%
Other9.2%
Ireland1.4%
United Kingdom1.3%
Switzerland1.2%
Netherlands0.4%
Distributions
| Date | Per unit |
|---|---|
| Dec 23, 2025 | $0.9097 |
| Sep 23, 2025 | $0.1027 |
| Jun 24, 2025 | $0.2190 |
| Mar 25, 2025 | $0.1071 |
| Jun 25, 2024 | $0.1502 |
| Mar 19, 2024 | $0.1606 |
| Dec 21, 2023 | $0.2097 |
| Sep 19, 2023 | $0.0404 |
| Jun 21, 2023 | $0.1800 |
| Dec 23, 2019 | $0.1062 |
| Sep 24, 2019 | $0.2168 |
| Jun 25, 2019 | $0.7400 |
| Mar 19, 2019 | $2.1946 |
| Dec 27, 2018 | $1.9242 |
| Sep 25, 2018 | $1.9080 |
| Jun 19, 2018 | $0.3864 |
| Dec 13, 2017 | $2.6600 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in LABU in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error